Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Period	Milestone	Group	Participants
Initial Study	STARTED	Low Dose 12-week	53
Initial Study	STARTED	Low Dose 24-week	53
Initial Study	STARTED	High Dose 12-week	52
Initial Study	STARTED	High Dose 24-week	54
Initial Study	STARTED	Placebo	47
Initial Study	COMPLETED	Low Dose 12-week	47
Initial Study	COMPLETED	Low Dose 24-week	48
Initial Study	COMPLETED	High Dose 12-week	42
Initial Study	COMPLETED	High Dose 24-week	43
Initial Study	COMPLETED	Placebo	42
Initial Study	NOT COMPLETED	Low Dose 12-week	6
Initial Study	NOT COMPLETED	Low Dose 24-week	5
Initial Study	NOT COMPLETED	High Dose 12-week	10
Initial Study	NOT COMPLETED	High Dose 24-week	11
Initial Study	NOT COMPLETED	Placebo	5
Study Extension	STARTED	Low Dose 12-week	33
Study Extension	STARTED	Low Dose 24-week	37
Study Extension	STARTED	High Dose 12-week	30
Study Extension	STARTED	High Dose 24-week	32
Study Extension	STARTED	Placebo	26

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02267356/flow